These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36378855)

  • 21. Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes.
    Lin MH; Connor CG; Ruedy KJ; Beck RW; Kollman C; Buckingham B; Redondo MJ; Schatz D; Haro H; Lee JM; Tamborlane WV; Wood JR;
    Diabetes Technol Ther; 2013 Nov; 15(11):929-34. PubMed ID: 23869706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Longitudinal View of Disparities in Insulin Pump Use Among Youth with Type 1 Diabetes: The SEARCH for Diabetes in Youth Study.
    Everett EM; Wright D; Williams A; Divers J; Pihoker C; Liese AD; Bellatorre A; Kahkoska AR; Bell R; Mendoza J; Mayer-Davis E; Wisk LE
    Diabetes Technol Ther; 2023 Feb; 25(2):131-139. PubMed ID: 36475821
    [No Abstract]   [Full Text] [Related]  

  • 23. Improving Equitable Access to Continuous Glucose Monitors for Alabama's Children with Type 1 Diabetes: A Quality Improvement Project.
    Schmitt J; Fogle K; Scott ML; Iyer P
    Diabetes Technol Ther; 2022 Jul; 24(7):481-491. PubMed ID: 35156834
    [No Abstract]   [Full Text] [Related]  

  • 24. Lessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapy.
    Olivier P; Lawson ML; Huot C; Richardson C; Nakhla M; Romain J
    J Diabetes Sci Technol; 2014 May; 8(3):523-8. PubMed ID: 24876616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mediating Effects of Technology-Based Therapy on the Relationship Between Socioeconomic Status and Glycemic Management in Pediatric Type 1 Diabetes.
    Stanley JR; Clarke ABM; Shulman R; Mahmud FH
    Diabetes Technol Ther; 2023 Mar; 25(3):186-193. PubMed ID: 36409503
    [No Abstract]   [Full Text] [Related]  

  • 26. Observed Characteristics Associated with Diabetes Device Use Among Teens with Type 1 Diabetes.
    Chen CW; Tinsley LJ; Volkening LK; Anderson BJ; Laffel LM
    J Diabetes Sci Technol; 2023 Jan; 17(1):186-194. PubMed ID: 34652236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry.
    Szypowska A; Schwandt A; Svensson J; Shalitin S; Cardona-Hernandez R; Forsander G; Sundberg F; De Beaufort C; Maahs D; Maffeis C; O'Riordan SM; Krisane ID; Scharf M; Castro S; Konstantinova M; Obermannova B; Casteels K; Gökşen D; Galhardo J; Kanaka-Gantenbein C; Rami-Merhar B; Madacsy L;
    Pediatr Diabetes; 2016 Oct; 17 Suppl 23():38-45. PubMed ID: 27417128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
    Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES
    Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Socioeconomic Disparities in Pump Uptake Among Children With Type 1 Diabetes in 2 Canadian Provinces With Different Payment Models.
    Ladd JM; Sharma A; Rahme E; Kroeker K; Dubé M; Simard M; Plante C; Blais C; Brownell M; Rodd C; Nakhla M
    JAMA Netw Open; 2022 May; 5(5):e2210464. PubMed ID: 35507342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HbA1c Levels in Type 1 Diabetes from Early Childhood to Older Adults: A Deeper Dive into the Influence of Technology and Socioeconomic Status on HbA1c in the T1D Exchange Clinic Registry Findings.
    Miller KM; Beck RW; Foster NC; Maahs DM
    Diabetes Technol Ther; 2020 Sep; 22(9):645-650. PubMed ID: 31905008
    [No Abstract]   [Full Text] [Related]  

  • 33. Pediatric Medicaid Patients With Type 1 Diabetes Benefit From Continuous Glucose Monitor Technology.
    Ravi SJ; Coakley A; Vigers T; Pyle L; Forlenza GP; Alonso T
    J Diabetes Sci Technol; 2021 May; 15(3):630-635. PubMed ID: 32172603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry.
    Wong JC; Foster NC; Maahs DM; Raghinaru D; Bergenstal RM; Ahmann AJ; Peters AL; Bode BW; Aleppo G; Hirsch IB; Kleis L; Chase HP; DuBose SN; Miller KM; Beck RW; Adi S;
    Diabetes Care; 2014 Oct; 37(10):2702-9. PubMed ID: 25011947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes Technology Use Among Pregnant and Nonpregnant Women with T1D in the T1D Exchange.
    Polsky S; Wu M; Bode BW; DuBose SN; Goland RS; Maahs DM; Foster NC; Peters AL; Levy CJ; Shah VN; Beck RW
    Diabetes Technol Ther; 2018 Aug; 20(8):517-523. PubMed ID: 29990438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW
    JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.
    Foster NC; Beck RW; Miller KM; Clements MA; Rickels MR; DiMeglio LA; Maahs DM; Tamborlane WV; Bergenstal R; Smith E; Olson BA; Garg SK
    Diabetes Technol Ther; 2019 Feb; 21(2):66-72. PubMed ID: 30657336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of Access to Diabetes Technology Depending on Area Deprivation and Demographics Between 2016 and 2019 in Germany.
    Auzanneau M; Rosenbauer J; Maier W; von Sengbusch S; Hamann J; Kapellen T; Freckmann G; Schmidt S; Lilienthal E; Holl RW
    J Diabetes Sci Technol; 2021 Sep; 15(5):1059-1068. PubMed ID: 34253084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving pediatric endocrinology trainees' knowledge about insulin pumps and continuous glucose monitors with online spaced education: Technology Knowledge Optimization in T1D (TeKnO T1D).
    Marks BE; Waldman G; Reardon K; Terrio S; Kumar A; Stafford DEJ; Garvey KC; Wolfsdorf JI
    Pediatr Diabetes; 2020 Aug; 21(5):814-823. PubMed ID: 32222056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.